Allan-Herndon-Dudley syndrome

Jump to navigation Jump to search

WikiDoc Resources for Allan-Herndon-Dudley syndrome

Articles

Most recent articles on Allan-Herndon-Dudley syndrome

Most cited articles on Allan-Herndon-Dudley syndrome

Review articles on Allan-Herndon-Dudley syndrome

Articles on Allan-Herndon-Dudley syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Allan-Herndon-Dudley syndrome

Images of Allan-Herndon-Dudley syndrome

Photos of Allan-Herndon-Dudley syndrome

Podcasts & MP3s on Allan-Herndon-Dudley syndrome

Videos on Allan-Herndon-Dudley syndrome

Evidence Based Medicine

Cochrane Collaboration on Allan-Herndon-Dudley syndrome

Bandolier on Allan-Herndon-Dudley syndrome

TRIP on Allan-Herndon-Dudley syndrome

Clinical Trials

Ongoing Trials on Allan-Herndon-Dudley syndrome at Clinical Trials.gov

Trial results on Allan-Herndon-Dudley syndrome

Clinical Trials on Allan-Herndon-Dudley syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Allan-Herndon-Dudley syndrome

NICE Guidance on Allan-Herndon-Dudley syndrome

NHS PRODIGY Guidance

FDA on Allan-Herndon-Dudley syndrome

CDC on Allan-Herndon-Dudley syndrome

Books

Books on Allan-Herndon-Dudley syndrome

News

Allan-Herndon-Dudley syndrome in the news

Be alerted to news on Allan-Herndon-Dudley syndrome

News trends on Allan-Herndon-Dudley syndrome

Commentary

Blogs on Allan-Herndon-Dudley syndrome

Definitions

Definitions of Allan-Herndon-Dudley syndrome

Patient Resources / Community

Patient resources on Allan-Herndon-Dudley syndrome

Discussion groups on Allan-Herndon-Dudley syndrome

Patient Handouts on Allan-Herndon-Dudley syndrome

Directions to Hospitals Treating Allan-Herndon-Dudley syndrome

Risk calculators and risk factors for Allan-Herndon-Dudley syndrome

Healthcare Provider Resources

Symptoms of Allan-Herndon-Dudley syndrome

Causes & Risk Factors for Allan-Herndon-Dudley syndrome

Diagnostic studies for Allan-Herndon-Dudley syndrome

Treatment of Allan-Herndon-Dudley syndrome

Continuing Medical Education (CME)

CME Programs on Allan-Herndon-Dudley syndrome

International

Allan-Herndon-Dudley syndrome en Espanol

Allan-Herndon-Dudley syndrome en Francais

Business

Allan-Herndon-Dudley syndrome in the Marketplace

Patents on Allan-Herndon-Dudley syndrome

Experimental / Informatics

List of terms related to Allan-Herndon-Dudley syndrome


Allan-Herndon-Dudley syndrome is a rare disorder of brain development that causes moderate to severe mental retardation and problems with movement. This condition, which occurs exclusively in males, disrupts development from before birth.

Most children with Allan-Herndon-Dudley syndrome have weak muscle tone (hypotonia) and underdevelopment of many muscles (muscle hypoplasia). As they get older, they usually develop joint deformities called contractures, which restrict the movement of certain joints. Abnormal muscle stiffness (spasticity), muscle weakness, and involuntary movements of the arms and legs also limit mobility. As a result, many people with Allan-Herndon-Dudley syndrome are unable to walk independently and become wheelchair-bound by adulthood.

Mutations in the SLC16A2 gene cause Allan-Herndon-Dudley syndrome. The SLC16A2 gene, also known as MCT8, provides instructions for making a protein that plays a critical role in the development of the nervous system. This protein transports a particular hormone into nerve cells in the developing brain. This hormone, called triiodothyronine or T3, is produced by the thyroid. T3 appears to be critical for the normal formation and growth of nerve cells, as well as the development of junctions between nerve cells (synapses) where cell-to-cell communication occurs. T3 and other forms of thyroid hormone also help regulate the development of other organs and control the rate of chemical reactions in the body.

Gene mutations alter the structure and function of the SLC16A2 protein. As a result, this protein is unable to transport T3 into nerve cells effectively. A lack of this critical hormone in certain parts of the brain disrupts normal brain development, resulting in mental retardation and problems with movement. Because T3 is not taken up by nerve cells, excess amounts of this hormone continue to circulate in the bloodstream. Increased T3 levels in the blood may be toxic to some organs and contribute to the signs and symptoms of Allan-Herndon-Dudley syndrome.

This condition is inherited in an X-linked recessive pattern. A condition is considered X-linked if the mutated gene that causes the disorder is located on the X chromosome, one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a mutation must be present in both copies of the gene to cause the disorder. Males are affected by X-linked recessive disorders much more frequently than females. A striking characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.

X-linked recessive inheritance
X-linked recessive inheritance

In X-linked recessive inheritance, a female with one altered copy of the gene in each cell is called a carrier. She can pass on the mutated gene, but usually does not experience signs and symptoms of the disorder. Carriers of SLC16A2 mutations have normal intelligence and do not experience problems with movement. Some carriers have been diagnosed with thyroid disease, a condition which is relatively common in the general population. It is unclear whether thyroid disease is related to SLC16A2 mutations in these cases.

References


Template:WS